Trial intelligence / Profile preview

PEG 3350 vs Placebo in Constipated Children

NCT00153114Phase 4Completed

Sponsor
Braintree Laboratories
Start
Jan 2003
Primary completion
Sep 2004
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

A Phase 4 trial of polyethylene glycol 3350 in constipation, sponsored by Braintree Laboratories. Started Jan 2003; status: completed.

02

Drugs

polyethylene glycol 3350
03

Conditions

constipation

Beyond the preview

Go deeper on NCT00153114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00153114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call